Pandora A/S (PNDZF)

SpringWorks Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	12,388	14,412	11,382	6,278	11,955	11,153
Market Cap Growth	-9.29%	26.63%	81.29%	-47.48%	7.18%	175.53%
Enterprise Value	14,649	16,425	13,266	7,596	12,539	12,281
Last Close Price	169.10	174.58	131.19	74.16	120.13	110.21
PE Ratio	15.94	19.86	16.19	8.69	18.79	35.02
PS Ratio	2.66	3.28	2.73	1.65	3.34	3.57
PB Ratio	22.31	18.85	14.33	6.10	11.16	9.19
P/TBV Ratio	-	-	-	-	-	152.17
P/FCF Ratio	12.35	14.06	12.27	12.15	13.18	12.12
P/OCF Ratio	10.37	11.91	10.39	9.86	12.55	11.36
EV/Sales Ratio	2.91	3.74	3.18	2.00	3.50	3.93
EV/EBITDA Ratio	8.91	13.17	11.25	6.96	12.39	15.71
EV/EBIT Ratio	11.56	14.84	12.71	7.84	14.18	20.03
EV/FCF Ratio	14.60	16.02	14.30	14.70	13.82	13.34
Debt / Equity Ratio	3.97	2.43	2.09	1.06	0.56	0.82
Debt / EBITDA Ratio	1.45	1.30	1.22	0.87	0.51	1.04
Debt / FCF Ratio	2.20	1.82	1.79	2.11	0.66	1.08
Asset Turnover	1.28	1.23	1.23	1.31	1.21	0.92
Inventory Turnover	1.42	1.49	1.44	1.74	2.26	2.19
Quick Ratio	0.28	0.47	0.47	0.29	0.35	0.47
Current Ratio	0.80	0.93	0.99	0.69	0.73	0.71
Return on Equity (ROE)	137.62%	96.23%	75.71%	70.99%	57.82%	30.67%
Return on Assets (ROA)	20.09%	19.33%	19.20%	20.78%	18.76%	11.22%
Return on Capital (ROIC)	27.70%	28.13%	28.13%	32.82%	29.65%	16.23%
Return on Capital Employed (ROCE)	47.70%	44.60%	44.70%	62.30%	56.20%	36.60%
Earnings Yield	6.27%	5.04%	6.18%	11.51%	5.32%	2.86%
FCF Yield	8.10%	7.11%	8.15%	8.23%	7.59%	8.25%
Dividend Yield	1.73%	1.59%	2.04%	3.10%	2.04%	-
Payout Ratio	29.22%	28.14%	29.79%	30.10%	-	42.57%
Buyback Yield / Dilution	4.95%	6.00%	8.13%	6.00%	-2.31%	0.53%
Total Shareholder Return	6.68%	7.59%	10.16%	9.10%	-0.27%	0.53%

Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.